Publications by authors named "Alfred Morgenstern"

134Publications

Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA.

Eur Urol 2021 Mar 5;79(3):343-350. Epub 2020 Dec 5.

Department of Nuclear Medicine, School of Medicine, Technical University of Munich, Munich, Germany; German Cancer Consortium (DKTK), partnersite Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany.

View Article and Find Full Text PDF
March 2021

An octadentate bis(semicarbazone) macrocycle: a potential chelator for lead and bismuth radiopharmaceuticals.

Dalton Trans 2020 Nov;49(42):14962-14974

School of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital, London SE1 7EH, UK.

View Article and Find Full Text PDF
November 2020

First-Generation Bispidine Chelators for Bi Radiopharmaceutical Applications.

ChemMedChem 2020 08 2;15(16):1591-1600. Epub 2020 Jul 2.

Universität Heidelberg, Anorganisch-Chemisches Institut, Neuenheimer Feld 270, 69120, Heidelberg, Germany.

View Article and Find Full Text PDF
August 2020

First patient exceeding 5-year complete remission after Ac-PSMA-TAT.

Eur J Nucl Med Mol Imaging 2021 Jan 28;48(1):311-312. Epub 2020 May 28.

European Commission, Joint Research Centre, Directorate for Nuclear Safety and Security, Karlsruhe, Germany.

View Article and Find Full Text PDF
January 2021

Supply and Clinical Application of Actinium-225 and Bismuth-213.

Semin Nucl Med 2020 03 21;50(2):119-123. Epub 2020 Feb 21.

European Commission, Joint Research Centre, Directorate for Nuclear Safety and Security, Karlsruhe, Germany.

View Article and Find Full Text PDF
March 2020

Prostate-specific membrane antigen-targeted endoradiotherapy in metastatic prostate cancer.

Curr Opin Urol 2020 01;30(1):98-105

Department of Nuclear Medicine, University of Pretoria, Pretoria, South Africa European Commission, Joint Research Centre, Directorate for Nuclear Safety and Security, Karlsruhe, Germany.

View Article and Find Full Text PDF
January 2020

Development of Targeted Alpha Therapy from Bench to Bedside.

J Med Imaging Radiat Sci 2019 Dec 9;50(4S1):S18-S20. Epub 2019 Aug 9.

European Commission, Joint Research Centre, Directorate for Nuclear Safety and Security, Karlsruhe, Germany.

View Article and Find Full Text PDF
December 2019

Targeted alpha therapy with bismuth-213 and actinium-225: Meeting future demand.

J Labelled Comp Radiopharm 2019 Sep 1;62(11):794-802. Epub 2019 Aug 1.

European Commission, Joint Research Centre (JRC), Karlsruhe, Germany.

View Article and Find Full Text PDF
September 2019

Correction to: Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study.

Eur J Nucl Med Mol Imaging 2019 Sep;46(10):1988

Department of Nuclear Medicine, Steve Biko Academic Hospital, University of Pretoria, Private Bag X169, Pretoria, 0001, South Africa.

View Article and Find Full Text PDF
September 2019

Assessment of Bi-anti-EGFR MAb treatment efficacy in malignant cancer cells with [1-C]pyruvate and [F]FDG.

Sci Rep 2019 06 5;9(1):8294. Epub 2019 Jun 5.

Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Department of Nuclear Medicine, Munich, Germany.

View Article and Find Full Text PDF
June 2019

Treatment of brain metastases of castration-resistant prostate cancer with Ac-PSMA-617.

Eur J Nucl Med Mol Imaging 2019 Jul 21;46(8):1756-1757. Epub 2019 May 21.

Department of Nuclear Medicine, University of Pretoria, Private Bag X169, Pretoria, 0001, South Africa.

View Article and Find Full Text PDF
July 2019